Research output per year
Research output per year
Search results
-
2003
Cognition is a poor predictor of the costs of care in Alzheimer's disease
Hills, R., Gray, R., Brettell, E., Bentham, P. & Raftery, J., 1 Jan 2003, p. 102. 1 p.Research output: Contribution to conference (unpublished) › Paper
-
Functionality, behaviour and age, but not cognition or donepezil treatment, predict institutionalisation in Alzheimer's Disease
Gray, R., Hills, R., Bentham, P., Brettell, E., Hardyman, W. & Raftery, J., 1 Jan 2003, p. 100. 1 p.Research output: Contribution to conference (unpublished) › Paper
-
2002
An independent randomized, placebo-controlled trial of the effect of donepezil on socially meaningful outcomes in 566 typical patients with Alzheimer's disease
Gray, R., Bentham, P., Brettell, E., Courtney, C., Hills, R. & Raferty, J., 1 Jan 2002, p. Abs 2036.Research output: Contribution to conference (unpublished) › Paper
-
Drop-out bias undermines findings of improved functionality with cholinesterase inhibitors
Hills, R., Gray, R., Harrison, R. & Bentham, P., 1 Jan 2002, p. S89 Abs338.Research output: Contribution to conference (unpublished) › Paper
-
Secondary acute myeloid leukaemia has a worse outcome than de novo AML, even taking into account cytogenetics and age. AML10,11,12 MRC Trials
Goldstone, AH., Burnett, AK., Avivi, I., Hills, R. & Wheatley, K., 1 Jan 2002, p. 88a Abs322.Research output: Contribution to conference (unpublished) › Paper
-
Twelve-week response to cholinesterase inhibitors does not predict future benefit: The AD 2000 trial experience
Bentham, P., Gray, R., Hills, R., Brettell, E. & Courtney, C., 1 Jan 2002, p. S89.Research output: Contribution to conference (unpublished) › Paper